Fresenius SE & Co. KGaA buy Kirus
Start price
04.05.21
/
50%
€40.55
Target price
04.05.22
€55.00
Performance (%)
-11.84%
End price
05.05.22
€35.75
Summary
This prediction ended on 05.05.22 with a price of €35.75. The prediction for Fresenius SE & Co. KGaA disappointed with a performance of -11.84%. A total of €0.88 was paid as dividends for this prediction. Kirus has 50% into this predictionFresenius is a German healthcare company listed on the Frankfurt and New York stock exchanges under the symbol FSNUF. The company is primarily engaged in the production and distribution of medical devices, pharmaceuticals, and services related to renal dialysis, critical care, and hospital operations. With over 290,000 employees and operations in more than 100 countries, Fresenius is one of the largest healthcare providers in the world. The company has experienced steady growth over the years, driven by its innovative product portfolio, strategic acquisitions, and a focus on operational efficiency.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fresenius SE & Co. KGaA | 2.643% | 2.643% | 6.627% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% |
According to Kirus what are the pros and cons of Fresenius SE & Co. KGaA for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Undervalued
Cons
Comments by Kirus for this prediction
In the thread Fresenius SE & Co. KGaA diskutieren
Buy mit Kursziel 55,0
In the thread Trading Fresenius SE & Co. KGaA
Die von Kirus gewählte maximale Laufzeit wurde überschritten